GE HealthCare has delivered the initial subject doses of Flyrcado (flurpiridaz F 18) injection, for coronary artery disease ...

Leading Spanish neuroradiologists presented a unique multicentre registry to boost stroke treatment at the 12th Triángulo ...

Discover a study where patients initially receiving placebo experienced notable improvement after switching to tildrakizumab.

A new study, published today in The Lancet Respiratory Medicine, has tested whether a set of interventions to keep lungs ...

Sellas Life Sciences has reported the multicentre Phase IIa trial data of a highly selective cyclin-dependent kinase 9 (CDK9) ...

The following is a summary of “Neurological manifestations in patients with VEXAS syndrome,” published in the February 2025 ...

Thinning hair is reversible and can fill out again, depending on the cause. Learn about hormonal hair loss, the role of ...

In their Article in The Lancet Respiratory Medicine, Ana Fernandez-Bustamante and colleagues report results of the PRIME-AIR ...

Objectives Existing scores are not accurate at predicting mortality in upper (UGIB) and lower (LGIB) gastrointestinal bleeding. We aimed to develop and validate a new pre-endoscopy score for ...

The following is a summary of “A Phase 2 randomised trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients ...

An AI-powered tool called MELD Graph is revolutionizing epilepsy care by detecting subtle brain abnormalities that ...

Scientists have developed an AI-powered tool that detects 64% of brain abnormalities linked to epilepsy that human radiologists miss.